Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print)
2020 / N 3

Вакцинопрофилактика COVID-19
Д.В. Пахомов

References

1. World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV) – United Arab Emirates. Disease outbreak news: update. 31 January 2020.
2. European Centre for Disease Prevention and Control (ECDC). Distribution of confirmed cases of MERS-CoV by place of infection and month of onset, from March 2012 to 2 December 2019. Published 2019 Dec 06.
3. Kovyrshina AV, Dolzhikova IV, Grousova DM, Balyasin MV, Botikov AG, Panina LV, Gordeychuk IV, Gulyaev SA, Zubkova OV, Ozharovskaya TA, Popova O, Tukhvatulin AI, Tokarskaya EA, Simakova YaV, Yesmagambetov IB, Shcheblyakov DV, Yevgrafova IM, Deryabin PG, Borisevich SV, Naroditskiy BS, Logunov DYu, Ginzburg AL. Combined vector vaccine for prevention of Middle East respiratory syndrome induces formation of long-term protective immune response to MERS-CoV coronavirus. Immunologiya 2020;41(2):135-43 (In Russian).
4. Logunov DY, Dolzhnikiva IV, Zubkova OV, Tukhvatulin AI, Scherblyakov DV, Dzharulaeva AS, Grousova DM, Erokhova AS, Kovyrshina AV, Botikov AG, Izhaeva FM, Popova O, Ozharovskaya TA, Yesmagambetov IB, Favorskaya IA, Zrelkin DI, Voronina DV, Shcherbinin DN, Semikhin AS, Simakova YV, Tokarskaya EA, Lubenets NL, Yegorova DA, Shmarov MM, Nikitenko NA, Morozova LF, Smolyarchuk EA, Kryukov EV, Babira VF, Borisevich SV, Naroditsky BS, Gintsburg AL. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia. The Lancet 2020 Sep;396(10255):887-97.
5. Logunov DY, Dolzhnikiva IV, Scherblyakov DV, Tukhvatulin AI, Zubkova OV, Dzharulaeva AS, Kovyrshina AV, Lubenets NL, Grousova DM, Yerokhova AS, Botikov AG, Izhaeva FM, Popova O, Ozharovskaya TA, Yesmagambetov IB, Favorskaya IA, Zrelkin DI, Voronina DV, Shcherbinin DN, Semikhin AS, Simakova YV, Tokarskaya EA, Yegorova DA, Shmarov MM, Nikitenko NA, Gushchin VA, Smolyarchuk EA, Zyryanov SK, Borisevich SV, Naroditsky BS, Gintsburg AL; Gam-COVID-Vac Vaccine Trial Group. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. The Lancet 2021 Feb;397(10275):671-81.
6. Immunoprophylaxis of pneumococcal infections: guidelines. Briko NI, editor. Moscow, 2013. 278 p. (In Russian).
7. Clinical immunology in respiratory medicine: guidelines. 2nd ed., revised. Kostinov MP, Chuchalin AG, editors. Moscow: MDV; 2018. 304 p. (In Russian).
8. Respiratory medicine: guidelines. 2nd ed., revised. Chuchalin AG, editor. Moscow: Litterra; 2017: 173-83 (In Russian).
9. Protasov AD, Zhestkov AV, Lavrentyeva NE, Kostinov MP, Ryzhov AA. Effect of complex vaccination against pneumococcal, hemophilic type B infections and influenza in patients with chronic obstructive pulmonary disease. Journal of Microbiology, Epidemiology, and Immunobiology 2011;4:80-4 (In Russian).
10. Vaccination against hepatitis B, influenza and rubella in adult patients with chronic diseases: guidelines. Kostinov MP, Zverev VV, editors. Moscow: MDV; 2009. 196 p. (In Russian).
11. Solovyeva IL, Kostinov MP, Kuselman AI. Vaccination of children with altered premorbid background against hepatitis B, measles, mumps. Ulyanovsk: Ulyanovsk State University; 2006. 296 p. (In Russian).
12. Kostinov MP, Maleyev VV. Hib-infection: vaccine prevention. Moscow: Meditsina Dlya Vsekh; 1998. 77 p. (In Russian).
13. Kostinov MP. Immunopathogenic properties of SARS-CoV-2 as a basis for the choice of pathogenetic therapy. Immunologiya 2020;41(1):83-91 (In Russian).
14. Fundamentals of immunorehabilitation in new coronovirus infection (COVID-19): guidelines for physicians. Kostinov MP, editor. Moscow: MDV; 2020. 112 p. (In Russian).
15. Kostinov MP. Vaccination of adults – from strategy to tactics: guidelines for physicians. Moscow: MDV; 2020. 248 p. (In Russian).
16. Kostinov MP, Svitich OA, Markelova EV. Potential immunoprophylaxis of COVID-19 in high-risk groups of infection. Temporary guidelines for physicians. Moscow: MDV; 2020. 60 p. (In Russian).
17. Kostinov MP, Markelova EV, Svitich OA, Polishchuk VB. Immune mechanisms of SARS-CoV-2 and potential drugs for prevention and treatment of COVID-19. Pulmonologiya 2020;30(5):700-8 (In Russian).
18. Priority vaccination of respiratory infections during and after SARS-COV-2 pandemic: guidelines for physicians. Kostinov MP, Chuchalin AG, editors. Moscow: MDV; 2020. 32 p. (In Russian).
19. Kostinov AM, Kostinov MP. Susceptibility to SARS-CoV-2 vaccinated against Streptococcus pneumoniae – mechanisms of non-specific action of pneumococcal vaccine. GN Speranskiy Journal of Pediatrics 2020;99(6):183-9 (In Russian).
  

[ Содержание выпуска N 3 | Выпуски журнала | Список журналов ]